We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$137M
AUM Growth
+$8.91M
Cap. Flow
+$5.42M
Cap. Flow %
3.95%
Top 10 Hldgs %
25.75%
Holding
1,127
New
41
Increased
160
Reduced
183
Closed
74

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$2.38M
2
BEAT
BioTelemetry, Inc.
BEAT
+$1.32M
3
RPM icon
RPM International
RPM
+$798K
4
DIS icon
Walt Disney
DIS
+$758K
5
COST icon
Costco
COST
+$641K

Sector Composition

Rank Sector Weight
1 Technology 27.32%
2 Healthcare 15.28%
3 Financials 10.67%
4 Consumer Staples 7.75%
5 Consumer Discretionary 5.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBDP
401
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$12K 0.01%
+490
New +$12.2K
SNP
402
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
$12K 0.01%
179
+16
+10% +$1.16K
ANZ
403
DELISTED
AUSTRALIA & NW ZEAL ADS(RP5 SH
ANZ
$12K 0.01%
596
+120
+25% +$2.42K
KNBWY
404
DELISTED
KIRIN BREWERY LTD SPONSORED ADR
KNBWY
$12K 0.01%
573
-89
-13% -$1.86K
ANSS
405
DELISTED
Ansys
ANSS
$11K 0.01%
56
CCEP icon
406
Coca-Cola Europacific Partners
CCEP
$46.5B
$11K 0.01%
191
+20
+12% +$1.09K
DLTR icon
407
Dollar Tree
DLTR
$23.2B
$11K 0.01%
100
EDIV icon
408
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
$11K 0.01%
334
-170
-34% -$5.41K
FIVE icon
409
Five Below
FIVE
$11.2B
$11K 0.01%
89
FNDF icon
410
Schwab Fundamental International Large Company Index ETF
FNDF
$24.3B
$11K 0.01%
395
NOV icon
411
NOV
NOV
$7.42B
$11K 0.01%
511
+260
+104% +$6.28K
PRU icon
412
Prudential Financial
PRU
$41.6B
$11K 0.01%
113
REGN icon
413
Regeneron Pharmaceuticals
REGN
$69.1B
$11K 0.01%
34
-3
-8% -$999
RSPH icon
414
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$742M
$11K 0.01%
550
VOE icon
415
Vanguard Mid-Cap Value ETF
VOE
$23.7B
$11K 0.01%
100
XSLV icon
416
Invesco S&P SmallCap Low Volatility ETF
XSLV
$250M
$11K 0.01%
225
CTXS
417
DELISTED
Citrix Systems Inc
CTXS
$11K 0.01%
117
-21
-15% -$2.06K
BSCL
418
DELISTED
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
$11K 0.01%
513
BSJJ
419
DELISTED
Invesco BulletShares 2019 High Yield Corporate Bond ETF
BSJJ
$11K 0.01%
450
DAL icon
420
Delta Air Lines
DAL
$55.8B
$10K 0.01%
181
-78
-30% -$4.37K
FMS icon
421
Fresenius Medical Care
FMS
$13.2B
$10K 0.01%
248
-6
-2% -$238
IYR icon
422
iShares US Real Estate ETF
IYR
$4.58B
$10K 0.01%
120
JNK icon
423
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.24B
$10K 0.01%
88
NXST icon
424
Nexstar Media Group
NXST
$5.61B
$10K 0.01%
98
+16
+20% +$1.72K
OGI
425
Organigram Holdings
OGI
$132M
$10K 0.01%
+400
New +$11.1K

Similar funds

Front Row Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Front Row Advisors held 1,127 positions worth $137M, up 6.9% from $128M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Front Row Advisors deployed $5.42M of net new capital in Q2 2019, opening 41 new positions and adding to 160 existing holdings. Its largest new stake was BioTelemetry, Inc.: 25,089 shares worth $1.21M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Microsoft, an estimated $206K trimmed.

  • Front Row Advisors's largest Q2 2019 buy was BioTelemetry, Inc.: 25,089 shares worth $1.21M.
  • Front Row Advisors added most to Medtronic in Q2 2019, an estimated $2.38M increase.
  • Front Row Advisors's biggest Q2 2019 reduction was Microsoft, cutting an estimated $206K.
  • Front Row Advisors fully exited iRobot in Q2 2019, selling an estimated $1.7M.
  • Front Row Advisors's ten largest holdings make up 26% of its $137M portfolio in Q2 2019.
  • Front Row Advisors opened 41 new positions and closed 74 in Q2 2019.
  • Front Row Advisors's portfolio value rose 6.9% quarter-over-quarter to $137M.

Based on Front Row Advisors's 13F filing for Q2 2019, filed 27 Aug 2019.